We have located links that may give you full text access.
Real-world Effectiveness of Statin Therapy in Adult Asthma.
Journal of Allergy and Clinical Immunology in Practice 2023 October 21
BACKGROUND: Blood lipids affect airway inflammation in asthma. Although several studies have suggested anti-inflammatory effects of statins on asthmatic airways, further studies are needed to clarify the long-term effectiveness of statins on asthma control and whether they are an effective treatment option.
OBJECTIVE: This study aimed to evaluate the long-term effectiveness of statins in the chronic management of adult asthma in real-world practice.
METHODS: Electronic medical record data spanning 28 years, collected from Ajou University Medical Center in Korea, were utilized to conduct a retrospective study. Clinical outcomes were compared between asthma patients who had maintained statin use (the statin group) and those not taking statins whose blood lipid tests were always normal (the nonstatin group). Propensity score matching (PSM) was performed, and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using the Cox proportional hazards model. Severe asthma exacerbation (SAE) was the primary outcome; asthma exacerbation (AE), asthma-related hospitalization, and new-onset type-2 diabetes mellitus (T2DM) and hypertension (HTN) were secondary outcomes.
RESULTS: After 1:1 PSM, the statin and nonstatin groups each included 545 adult asthma patients. The risk of SAEs and AEs was significantly lower in the statin group than in the nonstatin group (HR [95% CI]; 0.57 [0.35-0.90] and 0.71 [0.52-0.96], respectively). There were no significant differences in the risk of asthma-related hospitalization or new-onset T2DM or HTN between the two groups (0.76 [0.53-1.09], 2.33 [0.94-6.59], 1.71 [0.95-3.17], respectively).
CONCLUSIONS: Statin use is associated with a lower risk of AE with better clinical outcomes in adult asthma.
OBJECTIVE: This study aimed to evaluate the long-term effectiveness of statins in the chronic management of adult asthma in real-world practice.
METHODS: Electronic medical record data spanning 28 years, collected from Ajou University Medical Center in Korea, were utilized to conduct a retrospective study. Clinical outcomes were compared between asthma patients who had maintained statin use (the statin group) and those not taking statins whose blood lipid tests were always normal (the nonstatin group). Propensity score matching (PSM) was performed, and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using the Cox proportional hazards model. Severe asthma exacerbation (SAE) was the primary outcome; asthma exacerbation (AE), asthma-related hospitalization, and new-onset type-2 diabetes mellitus (T2DM) and hypertension (HTN) were secondary outcomes.
RESULTS: After 1:1 PSM, the statin and nonstatin groups each included 545 adult asthma patients. The risk of SAEs and AEs was significantly lower in the statin group than in the nonstatin group (HR [95% CI]; 0.57 [0.35-0.90] and 0.71 [0.52-0.96], respectively). There were no significant differences in the risk of asthma-related hospitalization or new-onset T2DM or HTN between the two groups (0.76 [0.53-1.09], 2.33 [0.94-6.59], 1.71 [0.95-3.17], respectively).
CONCLUSIONS: Statin use is associated with a lower risk of AE with better clinical outcomes in adult asthma.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app